Precision medicine based upon molecular testing is heralded as a revolution in how cancer
is prevented, diagnosed, and treated. Large efforts across the world aim to conduct …

Cervical cancer (CC) is the third most common malignancy in women globally, and
persistent infection with the oncogenic human papillomaviruses (HPV) is recognized as the …

In this study, we evaluated the association between high-risk human papillomavirus (hrHPV)
and the vaginal microbiome. Participants were recruited in Nigeria between April and …

Background Recent studies have suggested that the vaginal microenvironment plays a role
in persistence of high-risk human papillomavirus (hrHPV) infection and thus cervical …

Background The prevalence, persistence, and multiplicity of human papillomavirus (HPV)
infection appears different comparing HIV-positive to HIV-negative women. In this study, we …

Genetic variants that underlie susceptibility to cervical high-risk human papillomavirus
(hrHPV) infections are largely unknown. We conducted discovery genome-wide association …

Background Genetic factors may influence the susceptibility to high-risk (hr) human
papillomavirus (HPV) infection and persistence. We conducted the first genome-wide …

Globally, cervical cancer is the fourth most common cancer among women, with an
estimated 528 000 new cases in 2012. 1 Although it remains a significant public health …

Purpose There is a dearth of data on clearance of cervical human papillomavirus (HPV)
infection among women in West Africa. We examined the clearance of low-risk (lr) and high …

Most human papillomavirus (HPV) antiviral strategies have focused upon inhibiting viral
DNA replication, but it is increasingly apparent that viral DNA levels can be chemically …